95 related articles for article (PubMed ID: 2124241)
21. Elevated expression of the junB proto-oncogene is essential for v-fos induced transformation of Rat-1 cells.
Van Amsterdam JR; Wang Y; Sullivan RC; Zarbl H
Oncogene; 1994 Oct; 9(10):2969-76. PubMed ID: 8084600
[TBL] [Abstract][Full Text] [Related]
22. Cellular oncogenes and lymphocyte activation.
Schneider-Schaulies J; Knauer R; Schimpl A; Wecker E
Behring Inst Mitt; 1987 Jun; (81):110-9. PubMed ID: 3115245
[TBL] [Abstract][Full Text] [Related]
23. Defective nuclear translocation of nuclear factor of activated T cells and extracellular signal-regulated kinase underlies deficient IL-2 gene expression in Wiskott-Aldrich syndrome.
Cianferoni A; Massaad M; Feske S; de la Fuente MA; Gallego L; Ramesh N; Geha RS
J Allergy Clin Immunol; 2005 Dec; 116(6):1364-71. PubMed ID: 16337472
[TBL] [Abstract][Full Text] [Related]
24. Sublethal levels of oxidative stress stimulate transcriptional activation of c-jun and suppress IL-2 promoter activation in Jurkat T cells.
Beiqing L; Chen M; Whisler RL
J Immunol; 1996 Jul; 157(1):160-9. PubMed ID: 8683110
[TBL] [Abstract][Full Text] [Related]
25. Analysis of IL-2 gene regulation in c-fos transgenic mice. Evidence for an enhancement of IL-2 expression in splenic T cells stimulated via TCR/CD3 complex.
Ochi Y; Koizumi T; Kobayashi S; Phuchareon J; Hatano M; Takada M; Tomita Y; Tokuhisa T
J Immunol; 1994 Oct; 153(8):3485-90. PubMed ID: 7930571
[TBL] [Abstract][Full Text] [Related]
26. Aberrations in interleukin-1 expression in oncogene-transformed fibrosarcoma lines: constitutive interleukin-1 alpha transcription and manifestation of biological activity.
Douvdevani A; Huleihel M; Segal S; Apte RN
Eur Cytokine Netw; 1991; 2(4):257-64. PubMed ID: 1756231
[TBL] [Abstract][Full Text] [Related]
27. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas.
Ishiguro N; Matsui T; Shinagawa M
Am J Vet Res; 1993 Dec; 54(12):2010-4. PubMed ID: 8116930
[TBL] [Abstract][Full Text] [Related]
28. Transformation by Raf and other oncogenes renders cells differentially sensitive to growth inhibition by a dominant negative c-jun mutant.
Rapp UR; Troppmair J; Beck T; Birrer MJ
Oncogene; 1994 Dec; 9(12):3493-8. PubMed ID: 7970709
[TBL] [Abstract][Full Text] [Related]
29. Two different molecular pathways account for low IL-2 receptor and c-myc mRNA expression by lpr Lyt-2- L3T4- T cells.
Katagiri K; Katagiri T; Yokota S; Eisenberg RA; Cohen PL; Ting JP
J Immunol; 1988 Sep; 141(6):2145-52. PubMed ID: 3139753
[TBL] [Abstract][Full Text] [Related]
30. Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression.
Ruegemer JJ; Ho SN; Augustine JA; Schlager JW; Bell MP; McKean DJ; Abraham RT
J Immunol; 1990 Mar; 144(5):1767-76. PubMed ID: 2407783
[TBL] [Abstract][Full Text] [Related]
31. Expression of IL-2 and IL-4 in T lymphocytes transformed by herpesvirus saimiri.
Chou CS; Medveczky MM; Geck P; Vercelli D; Medveczky PG
Virology; 1995 Apr; 208(2):418-26. PubMed ID: 7747414
[TBL] [Abstract][Full Text] [Related]
32. Influence of the glucocorticoid receptor on c-fos inducibility in activated ras-containing mouse lung cells.
Johnson TA; Li J; Beer DG
Mol Carcinog; 1996 Oct; 17(2):70-7. PubMed ID: 8890955
[TBL] [Abstract][Full Text] [Related]
33. Eosinophilic inflammation: mechanisms regulating IL-5 transcription in human T lymphocytes.
Wang J; Young IG
Allergy; 2007 Oct; 62(10):1131-8. PubMed ID: 17845581
[TBL] [Abstract][Full Text] [Related]
34. Signal transduction mediated by the reconstituted IL-2 receptor. Evidence for a cell type-specific function of IL-2 receptor beta-chain.
Minami Y; Oishi I; Liu ZJ; Nakagawa S; Miyazaki T; Taniguchi T
J Immunol; 1994 Jun; 152(12):5680-90. PubMed ID: 8207200
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
[TBL] [Abstract][Full Text] [Related]
36. Activation of the CD2 pathway in lamina propria T cells up-regulates functionally active AP-1 binding to the IL-2 promoter, resulting in messenger RNA transcription and IL-2 secretion.
Gonsky R; Deem RL; Hughes CC; Targan SR
J Immunol; 1998 May; 160(10):4914-22. PubMed ID: 9590239
[TBL] [Abstract][Full Text] [Related]
37. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
[TBL] [Abstract][Full Text] [Related]
38. Expression of murine IL-2 receptor beta-chain on thymic and splenic lymphocyte subpopulations as revealed by the IL-2-induced proliferative response in human IL-2 receptor alpha-chain transgenic mice.
Hattori M; Okazaki H; Ishida Y; Onuma M; Kano S; Honjo T; Minato N
J Immunol; 1990 May; 144(10):3809-15. PubMed ID: 2332632
[TBL] [Abstract][Full Text] [Related]
39. The human papillomavirus type 16 E5 gene cooperates with the E7 gene to stimulate proliferation of primary cells and increases viral gene expression.
Bouvard V; Matlashewski G; Gu ZM; Storey A; Banks L
Virology; 1994 Aug; 203(1):73-80. PubMed ID: 8030286
[TBL] [Abstract][Full Text] [Related]
40. Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum.
Kolch W; Heidecker G; Troppmair J; Yanagihara K; Bassin RH; Rapp UR
Oncogene; 1993 Feb; 8(2):361-70. PubMed ID: 8426742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
